Axion Biosystems unveils Omni Pro 12 latest Throughput Live-Cell Imaging Platform

Axion BioSystems recently announced the addition of the Omni Pro 12 to the Omni live-cell imaging product family. The latest platform, featuring integrated robotics and a multi-plate design compatible with any standard incubator, offers enhanced flexibility and efficiency to scientists and drug developers conducting live-cell imaging experiments.

Kevin Gould, Axion BioSystems’ CEO

Kevin Gould, Axion BioSystems’ CEO stated “The Omni Pro 12 is designed to provide an automated solution to accommodate multiple users and support live-cell imaging applications. The device is highly intuitive, offering unparalleled ease-of-use and accessibility, which makes it an indispensable tool for every life science laboratory. From label-free, long-term cell monitoring to fluorescence-based assays, live-cell imaging can be an integral tool to advance immunology, oncology, and stem cell biology, facilitating the development of novel drugs and therapeutics.”

According to Jan-Willem Van Bree, Axion’s VP of Research & Development – Image Analysis Systems, the combination of a fully automated microplate storage and handling set-up with an Omni cell imager offers new possibilities for live-cell analysis. “The Omni Pro 12 increases the throughput without increasing the complexity of experimental setup or data analysis. The instrument is designed to operate inside a cell culture incubator, ensuring health and viability of even the most sensitive cell types, while integrated and user-friendly software enables the analysis of complex biological data in real-time.”

Industry sources added that non-invasively studying the real-time biology of live cells allows scientists to understand the fundamental biological processes underpinning health and disease and accelerate the discovery and development of lifesaving therapeutics. The Omni Pro 12 uses high-capacity brightfield and fluorescence imaging to continuously assess cell behavior and function without sacrificing cell health and viability. AI-driven image analysis software minimizes subjectivity in the interpretation of data, allowing users to gain a quantitative, rather than qualitative, assessment. Combining knowledge from biology, engineering, optics, and computer science, the Omni Pro 12 is a must-have in any modern lab.


Also read articles on different biotechnology companies:

Vesigen Therapeutics onboards Rakhshita Dhar to Board of Directors

Juvenescence onboards Dr Richard Marshall CBE as CEO


Recent News